Follow
Alessandro Rambaldi
Alessandro Rambaldi
Professore di Ematologia, Universitŕ degli Studi di Milano
Verified email at unimi.it
Title
Cited by
Cited by
Year
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ...
New England Journal of Medicine 376 (9), 836-847, 2017
17732017
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
1647*2013
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ...
Leukemia 13 (12), 1901-1928, 1999
15341999
Idecabtagene vicleucel in relapsed and refractory multiple myeloma
NC Munshi, LD Anderson Jr, N Shah, D Madduri, J Berdeja, S Lonial, ...
New England Journal of Medicine 384 (8), 705-716, 2021
14142021
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
MS Topp, N Gökbuget, AS Stein, G Zugmaier, S O'Brien, RC Bargou, ...
The Lancet Oncology 16 (1), 57-66, 2015
12802015
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
A Tefferi, P Guglielmelli, DR Larson, C Finke, EA Wassie, L Pieri, ...
Blood, The Journal of the American Society of Hematology 124 (16), 2507-2513, 2014
8192014
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
8102013
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
J Golay, L Zaffaroni, T Vaccari, M Lazzari, GM Borleri, S Bernasconi, ...
Blood, The Journal of the American Society of Hematology 95 (12), 3900-3908, 2000
7922000
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
S Horwitz, OA O'Connor, B Pro, T Illidge, M Fanale, R Advani, NL Bartlett, ...
The Lancet 393 (10168), 229-240, 2019
6792019
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012
6562012
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007
6332007
Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
Italian Cooperative Study Group on Chronic Myeloid Leukemia
New England Journal of Medicine 330 (12), 820-825, 1994
6071994
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
J Golay, M Lazzari, V Facchinetti, S Bernasconi, G Borleri, T Barbui, ...
Blood, The Journal of the American Society of Hematology 98 (12), 3383-3389, 2001
5542001
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
R Bassan, O Spinelli, E Oldani, T Intermesoli, M Tosi, B Peruta, G Rossi, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4153-4162, 2009
5242009
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among …
RM Emanuel, AC Dueck, HL Geyer, JJ Kiladjian, S Slot, S Zweegman, ...
Journal of clinical oncology 30 (33), 4098, 2012
5132012
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
S Viviani, PL Zinzani, A Rambaldi, E Brusamolino, A Levis, V Bonfante, ...
New England Journal of Medicine 365 (3), 203-212, 2011
5002011
MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis
P Guglielmelli, TL Lasho, G Rotunno, M Mudireddy, C Mannarelli, ...
Journal of Clinical Oncology 36 (4), 310-318, 2018
4922018
Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
AM Vannucchi, E Antonioli, P Guglielmelli, G Longo, A Pancrazzi, ...
Leukemia 21 (9), 1952-1959, 2007
4732007
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
M Morigi, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, ...
Stem cells 26 (8), 2075-2082, 2008
4712008
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ...
Nature genetics 51 (2), 296-307, 2019
4582019
The system can't perform the operation now. Try again later.
Articles 1–20